Bio-Techne Corp (NASDAQ: TECH) started the day on Wednesday, with a price decrease of -0.10% at $59.19, before settling in for the price of $59.25 at the close. Taking a more long-term approach, TECH posted a 52-week range of $46.01-$79.28.
In the past 5-years timespan, the Healthcare sector firm’s annual sales growth was -20.58%. Meanwhile, its Annual Earning per share during the time was -20.58%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 3.36%. This publicly-traded company’s shares outstanding now amounts to $155.75 million, simultaneously with a float of $153.94 million. The organization now has a market capitalization sitting at $9.22 billion. At the time of writing, stock’s 50-day Moving Average stood at $60.97, while the 200-day Moving Average is $55.22.
Bio-Techne Corp (TECH) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. Bio-Techne Corp’s current insider ownership accounts for 1.20%, in contrast to 104.95% institutional ownership. According to the most recent insider trade that took place on Aug 25 ’25, this organization’s Director sold 17,040 shares at the rate of 56.36, making the entire transaction reach 960,388 in total value, affecting insider ownership by 44,559. Preceding that transaction, on Aug 25 ’25, Company’s Director sold 17,040 for 56.21, making the whole transaction’s value amount to 957,818. This particular insider is now the holder of 44,863 in total.
Bio-Techne Corp (TECH) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.56 per share during the current fiscal year.
Bio-Techne Corp’s EPS increase for this current 12-month fiscal period is 3.36% and is forecasted to reach 2.21 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 10.06% through the next 5 years, which can be compared against the -20.58% growth it accomplished over the previous five years trading on the market.
Bio-Techne Corp (NASDAQ: TECH) Trading Performance Indicators
Let’s observe the current performance indicators for Bio-Techne Corp (TECH). It’s Quick Ratio in the last reported quarter now stands at 2.81. Alongside those numbers, its PE Ratio stands at $120.99, and its Beta score is 1.46. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 7.58. Similarly, its price to free cash flow for trailing twelve months is now 41.16.
In the same vein, TECH’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 0.49, a figure that is expected to reach 0.43 in the next quarter, and analysts are predicting that it will be 2.21 at the market close of one year from today.
Technical Analysis of Bio-Techne Corp (TECH)
If we take a close look at the recent performances of Bio-Techne Corp (NASDAQ: TECH), its last 5-days Average volume was 1.58 million that shows plunge from its year to date volume of 2.08 million. During the previous 9 days, stock’s Stochastic %D was recorded 58.22% While, its Average True Range was 47.92.
Raw Stochastic average of Bio-Techne Corp (TECH) in the period of the previous 100 days is set at 59.75%, which indicates a major rise in contrast to 35.21% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 1.86 that was lower than 2.03 volatility it exhibited in the past 100-days period.
